| Serial Number | 87914539 |
| Word Mark | GEOMX |
| Filing Date | Wednesday, May 9, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, June 16, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 11, 2018 |
| Goods and Services | diagnostic reagents and instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; chemical reagents for medical use; reagents for medical or veterinary use containing antibodies and nucleic acids; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical or veterinary diagnostic kits comprising medical or veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; diagnostic preparations in the nature of antibodies, for medical and veterinary purposes; reagents and diagnostic reagents for medical or veterinary purposes; diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes; medical or veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents and assays for testing of body fluids or tissue; kits consisting primarily of medical or veterinary diagnostic reagents and assays for testing of body fluids or tissue; reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical or veterinary purposes; medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents for use relating to molecular identification and digital quantification; medical diagnostic reagents containing antibodies and nucleic acids; medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridization detection; medical diagnostic reagents for use relating to molecular identification and digital quantification |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 18, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, September 5, 2018 |
| First Use In Commerce Date | Wednesday, September 5, 2018 |
| Party Name | NanoString Technologies, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98109 |
| Party Name | NanoString Technologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98109 |
| Event Date | Event Description |
| Saturday, May 12, 2018 | NEW APPLICATION ENTERED |
| Friday, May 18, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 30, 2018 | ASSIGNED TO EXAMINER |
| Friday, August 31, 2018 | PRIORITY ACTION WRITTEN |
| Friday, August 31, 2018 | PRIORITY ACTION E-MAILED |
| Friday, August 31, 2018 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Sunday, October 14, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, October 14, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 15, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 18, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 2, 2018 | ASSIGNED TO LIE |
| Friday, November 2, 2018 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, November 21, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 11, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 11, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 5, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, August 5, 2019 | SOU EXTENSION 1 FILED |
| Thursday, August 15, 2019 | TEAS PETITION TO REVIVE RECEIVED |
| Thursday, August 15, 2019 | PETITION TO REVIVE-GRANTED |
| Thursday, August 15, 2019 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Thursday, August 15, 2019 | NOTICE OF REVIVAL - E-MAILED |
| Wednesday, October 2, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 2, 2019 | SOU EXTENSION 1 GRANTED |
| Thursday, October 3, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 23, 2019 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, October 23, 2019 | DIVISIONAL REQUEST RECEIVED |
| Friday, October 25, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, October 28, 2019 | DIVISIONAL PROCESSING COMPLETE |
| Tuesday, October 29, 2019 | CORRECTED NOA E-MAILED |
| Thursday, January 30, 2020 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 30, 2020 | SOU EXTENSION 2 FILED |
| Thursday, January 30, 2020 | SOU EXTENSION 2 GRANTED |
| Saturday, February 1, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 20, 2020 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 20, 2020 | SOU EXTENSION 3 FILED |
| Monday, July 20, 2020 | SOU EXTENSION 3 GRANTED |
| Wednesday, July 22, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 20, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 20, 2021 | SOU EXTENSION 4 FILED |
| Wednesday, January 20, 2021 | SOU EXTENSION 4 GRANTED |
| Friday, January 22, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 5, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, August 5, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, August 5, 2021 | SOU EXTENSION 5 FILED |
| Thursday, August 5, 2021 | USE AMENDMENT FILED |
| Monday, August 16, 2021 | SOU EXTENSION 5 GRANTED |
| Monday, August 16, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, August 17, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 19, 2021 | ASSIGNED TO EXAMINER |
| Monday, August 30, 2021 | ASSIGNED TO EXAMINER |
| Friday, December 3, 2021 | SU - NON-FINAL ACTION - WRITTEN |
| Friday, December 3, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, December 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 16, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, June 16, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |